These findings collectively suggest that factor V Leiden and prothrombin G20210A mutations play a significant role in RPL across different populations, with specific thrombophilia profiles potentially influencing the timing and recurrence of pregnancy losses, highlighting the need for tailored screening and management approaches. This evidence concerns the gene F5 and Rare hereditary thrombophilia.